Investigation of the Impact of the Administration of Crocus Sativus L Extract on the Metabolic Control of Patients With Type 1 Diabetes Mellitus
| Registry | NCT05933460 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: quadruple, treatment |
| Enrollment | 61 (Actual) |
| Sponsor | Aristotle University Of Thessaloniki (Other) |
| Conditions | Diabetes Mellitus, Type 1, Diabetes type1 |
| Interventions | dietary supplement with probiotics, prebiotics, magnesium and saffron extract, dietary supplement with probiotics, prebiotics, magnesium (Dietary supplement) |
| Dates | start 2022-03-01, primary completion 2023-04-28, completion 2023-04-28, first posted 2023-07-06, last updated 2025-07-09 |
| Locations | 1 site in Greece |
Related Papers Related Patents Related Grants Related Experts
All trials for Diabetes Mellitus, Type 1 All trials for Diabetes type1 All trials of dietary supplement with probiotics, prebiotics, magnesium and saffron extract All trials of dietary supplement with probiotics, prebiotics, magnesium
Administration of 4 strain of probiotics, prebiotic, magnesium and crocus sativus extract in a sachet to people with diabetes mellitus type 1 for 6 months
Double blind placebo controlled randomized trial: A sachet of a combination of 4 strains of probiotics (Lactobacillus rhamnosus, Bifidobacterium animalis lactis, Bifidobacterium breve, Bifidobacterium longum), Fructooligosaccharides, Magnesium and Saffron extract was administered 3 times per day in people with diabetes type 1 for 6 months on continuous glucose monitoring systems.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Active Group | Experimental | Dietary Supplement: dietary supplement with probiotics, prebiotics, magnesium and saffron extract | A sachet of a combination of 4 strains of probiotics (1billion CFU) (Lactobacillus rhamnosus, Bifidobacterium animalis lactis, Bifidobacterium breve, Bifidobacterium longum), Fructooligosaccharides 100mg, Magnesium 75mg and Crocus sativus (Saffron extract 28mg) was administered 3 times per day in people with diabetes type 1 for 6 months on continuous glucose monitoring systems. |
| Placebo group | Placebo comparator | Dietary Supplement: dietary supplement with probiotics, prebiotics, magnesium | A sachet of a combination of 4 strains of probiotics (1billion CFU(Lactobacillus rhamnosus, Bifidobacterium animalis lactis, Bifidobacterium breve, Bifidobacterium longum), Fructooligosaccharides 100mg, Magnesium 75mg without crocus sativus was administered 3 times per day in people with diabetes type 1 for 6 months on continuous glucose monitoring systems. |
Sex: All, ages: 18 Years to any
Inclusion Criteria: * People with diabetes mellitus type 1 (with diabetes duration over 1 year) (adults <18 years old) wearing a continuous glucose monitoring system with or without an insulin pump Exclusion Criteria: * Pregnant * People with diabetes mellitus type 2 * Breastfeeding women * People with liver disease * People with chronic kidney disease (over stage 3) * People with allergy in crocus sativus * People that consume everyday herbs or supplements * People on anti platelet treatment not for prevention
| Facility | City | Country | Status |
|---|---|---|---|
| University General Hospital of Thessaloniki AHEPA | Thessaloniki, Central Macedonia | Greece |